Myasthenia gravis: Difference between revisions

Line 1: Line 1:
==Background==
==Background==
*Autoantibody degradation, dysfunction, and blockade of acetylcholine receptor at the NMJ
*Autoantibody degradation, dysfunction, and blockade of acetylcholine receptor at the NMJ<ref>Medications and Myasthenia Gravis (A Reference for Health Care Professionals) [http://www.myasthenia.org/LinkClick.aspx?fileticket=JuFvZPPq2vg%3d PDF]<?ref>
*Thymus is abnormal in 75% of pts
*Thymus is abnormal in 75% of pts
**Thymectomy resolves or improves symptoms in most pts, especially those with a thymoma
**Thymectomy resolves or improves symptoms in most pts, especially those with a thymoma

Revision as of 03:27, 31 January 2015

Background

  • Autoantibody degradation, dysfunction, and blockade of acetylcholine receptor at the NMJCite error: Closing </ref> missing for <ref> tag
  • Steroids
  • Anticonvulsants (phenytoin, barbiturates, lithium)
  • Psychotropics (haloperidol)
  • Beta-blockers / calcium-channel blockers
  • Local anesthetics
  • Narcotics
  • Anticholinergics (diphenhydramine)
  • NMJ blocking agents (roc, sux)

Weakness

Treatment

  • Always evaluate tidal volume, FEV, negative inspiratory force, ability to handle secretions
  1. Meds
    1. Pyridostigmine
      1. If pt's usual dose has been missed the next dose is usually doubled
      2. PO route: 60-90mg q4hr
      3. IV route: 1/30th of the PO dose (2-3mg) by slow IV infusion
    2. Neostigmine
      1. 0.5mg IV
  2. Intubation
    1. If possible avoid depolarizing AND non-depolarizing agents
      1. If pt requires paralysis use non-depolarizing agent at smaller dose
      2. If must use depolarizing agents, will need higher doses
  3. Plasmapherisis
  4. IVIG

See Also

Source

  • Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 7e (2010), Chapter 167. Chronic Neurologic Disorders